Scientists reported that nitric oxide synthase (NOS) blockade potentiated response of human metaplastic breast cancer cell lines and tumors to phosphoinositide 3-kinase (PI3K) inhibitor alpelisib and taxane.
[Nature Communications]
Home Newsletters Mammary Cell News NOS Inhibition Sensitizes Metaplastic Breast Cancer to PI3K Inhibition and Taxane Therapy...
